These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. The Mayo Clinic Histiocytosis Working Group Consensus Statement for the Diagnosis and Evaluation of Adult Patients With Histiocytic Neoplasms: Erdheim-Chester Disease, Langerhans Cell Histiocytosis, and Rosai-Dorfman Disease. Goyal G; Young JR; Koster MJ; Tobin WO; Vassallo R; Ryu JH; Davidge-Pitts CJ; Hurtado MD; Ravindran A; Sartori Valinotti JC; Bennani NN; Shah MV; Rech KL; Go RS; Mayo Clin Proc; 2019 Oct; 94(10):2054-2071. PubMed ID: 31472931 [TBL] [Abstract][Full Text] [Related]
11. [Erdheim-Chester disease and Rosai-Dorfman disease: Pathological, radiological and clinical features of adult non-Langerhans cell histiocytosis]. Bösmüller H; Nann D; Horger M; Fend F Pathologe; 2015 Sep; 36(5):458-66. PubMed ID: 26305142 [TBL] [Abstract][Full Text] [Related]
12. Intraosseous Rosai-Dorfman disease diagnosed by touch imprint cytology evaluation: A case series. Pendse AA; Wobker SE; Greene KG; Smith SV; Esther RJ; Dodd LG Diagn Cytopathol; 2018 Jan; 46(1):83-87. PubMed ID: 28834636 [TBL] [Abstract][Full Text] [Related]
13. Cutaneous Rosai-Dorfman disease: clinicopathological profiles, spectrum and evolution of 21 lesions in six patients. Wang KH; Chen WY; Liu HN; Huang CC; Lee WR; Hu CH Br J Dermatol; 2006 Feb; 154(2):277-86. PubMed ID: 16433797 [TBL] [Abstract][Full Text] [Related]